Amaç: Minimal invaziv kardiyak kateterizasyon (KK) işlemleri daha fazla tercih edilmektedir. Bu işlemlerde uygulanan prosedürel sedasyon ve analjezi (PSA) uygulamalarını değerlendirerek seçilmiş vakalarda genel anestezi (GA)'nin yerine kullanılabilirliğini göstermek istedik. Gereç ve Yöntemler: Etik kurul onamı alınan 18 yaşın altındaki çocuklarda, kardiyak hemodinamik görüntüleme ve işlem labaratuvarında, KK işlemlerinde, GA, ketamin ve propofol infüzyonu ile PSA uygulanan hastaların dosyalarından, ASA skoru, yaş, istenmeyen olaylar, yapılan işlem ve süresi, retrospektif olarak kayıt altına alındı. Bulgular: Çalışmaya 297 hasta dahil edildi. İşlemlerin %30,3'ü GA, %69,7'si PSA ile yapılmıştı. GA grubunda %63,3 oranı ile kız çocuklar fazla idi (p=0,031). Gruplar arasında ASA sınıflamasında fark bulunmadı (p=0,285). Hastaların ortalama yaşı 11,22 [standart sapma (SS) 4,54], en küçük yaş 1 ve en büyük yaş 18'di. İşlem süresi GA grubunda ortalama 106,56 dak. (SS 46,335) olup PSA grubunda 108,38 dak. (SS 47,566) idi. En kısa işlem 15, en uzun işlem 240 dakikaydı. Gruplar arasında süre açısından fark bulunmadı (p=0,760). Hastaların %11,8'inde (n=35) patent duktus arteriosus, %12,8'inde (n=38) atriyal septal defekt (ASD), %24,2'si (n=72) supraventriküler taşikardi, %42,8'inde (n=127) diğer ritim bozuklukları ve %2'sinde (n=6) ventriküler septal defekt (VSD) tanısı vardı. Transözofageal ekokardiyografi (TÖE) eşliğinde, ASD kapatılmasında %90, VSD'nin tamamında GA tercih edildi. Hastaların tanılarına göre seçilen tedavi yöntemleri arasındaki fark iki grupta anlamlıydı (p<0,001). PSA esnasında istenmeyen durumlar görülmedi. Sonuç: İşlem süreleri ve ASA skorları arasında fark olmayan gruplarda hastaların tanılarına göre anestezi yöntemi seçildiği görüldü. TÖE ile yapılan işlemlerde GA, çok uzun süren kardiyak elektrofizyolojik işlemlerde ise PSA ile işlem yaptırılabildi.
Anahtar Kelimeler: Prosedürel sedasyon analjezi; genel anestezi; kardiyak kateterizasyon işlemleri; pediatrik hasta
Objective: Minimally invasive cardiac catheterization (CC) procedures are increasingly preferred. Prosedürel sedation and analgesia (PSA) are replacing general anesthesia (GA) in selected procedures. We aimed to show that PSA could be used as an alternative to GA in CC procedures. Material and Methods: In patients under 18 years of age who received ethical committee approval, data (ASA scores, age, advers events, procedures and durations) was retrospectively collected from the files of those undergoing PSA (with ketamine and propofol) and GA. Results: The study included 297 patients. While 30.3% of the procedures were performed under GA, 69.7% were performed with PSA. There was no significant difference between the ASA scores of the groups (p=0.285). The average age of the patients was 11.22 years [median 12, standard deviation (SD) 4.54], with the youngest being 1 year old and the oldest 18 years old. The average procedure time was 106.56 minutes (SD 46.335) for the GA group and 108.38 minutes (SD 47.566) for the PSA group. The shortest procedure lasted 15 minutes, and the longest lasted 240 minutes. No significant difference in procedure times was found between the groups (p=0.760). Among the patients, 11.8% (n=35) had patent ductus arteriosus, 12.8% (n=38) had atrial septal defects, 24.2% (n=72) had supraventricular tachycardia, 42.8% (n=127) had other rhythm disorders, and 2% (n=6) had ventricular septal defects. GA was preferred in 90% of TEE-guided ASD closures and all VSD closures. The differences in treatment methods based on diagnoses were significant in both groups (p<0.001). No undesirable events were observed during PSA. Conclusion: It was determined that the choice of anesthesia method was based on the diagnoses of patients rather than the duration of procedures.PSA may be preferred in cardiac electrophysiological procedures lasting longer than 60 minutes.
Keywords: Procedural sedation and analgesia; general anesthesia; cardiac catheterization procedures; pediatric patient
- Kagiyama Y, Kenny D, Hijazi ZM. Current status of transcatheter intervention for complex right ventricular outflow tract abnormalities. Glob Cardiol Sci Pract. 2024;2024(1):e202407. [Crossref] [PubMed] [PMC]
- Marelli A, Beauchesne L, Colman J, Ducas R, Grewal J, Keir M, et al. Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart Disease. Can J Cardiol. 2022;38(7):862-96. [Crossref] [PubMed]
- Jalili M, Bahreini M, Doosti-Irani A, Masoomi R, Arbab M, Mirfazaelian H. Ketamine-propofol combination (ketofol) vs propofol for procedural sedation and analgesia: systematic review and meta-analysis. Am J Emerg Med. 2016;34(3):558-69. [Crossref] [PubMed]
- Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018: A Report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology. Anesthesiology. 2018;128(3):437-79. [PubMed]
- Poonai N, Canton K, Ali S, Hendrikx S, Shah A, Miller M, et al. Intranasal ketamine for procedural sedation and analgesia in children: A systematic review. PLoS One. 2017;12(3):e0173253. [Crossref] [PubMed] [PMC]
- Soliman R, Mofeed M, Momenah T. Propofol versus ketofol for sedation of pediatric patients undergoing transcatheter pulmonary valve implantation: a double-blind randomized study. Ann Card Anaesth. 2017;20(3):313-7. [Crossref] [PubMed] [PMC]
- Alletag MJ, Auerbach MA, Baum CR. Ketamine, propofol, and ketofol use for pediatric sedation. Pediatr Emerg Care. 2012;28(12):1391-5; quiz 1396-8. [Crossref] [PubMed]
- James R, Glen JB. Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. J Med Chem. 1980;23(12):1350-7. [Crossref] [PubMed]
- Ephros H, Shah S, Herrod RJ. A review of sedation agents. Oral Maxillofac Surg Clin North Am. 2022;34(1):21-34. [Crossref] [PubMed]
- Krasowski MD, Nishikawa K, Nikolaeva N, Lin A, Harrison NL. Methionine 286 in transmembrane domain 3 of the GABAA receptor beta subunit controls a binding cavity for propofol and other alkylphenol general anesthetics. Neuropharmacology. 2001;41(8):952-64. [Crossref] [PubMed] [PMC]
- Sellgren J, Ejnell H, Elam M, Pontén J, Wallin BG. Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. Anesthesiology. 1994;80(3):534-44. [Crossref] [PubMed]
- Gao M, Rejaei D, Liu H. Ketamine use in current clinical practice. Acta Pharmacol Sin. 2016;37(7):865-72. [Crossref] [PubMed] [PMC]
- Chizh BA. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol. 2007;21(3):259-71. [Crossref] [PubMed]
- Meller ST. Ketamine: relief from chronic pain through actions at the NMDA receptor? Pain. 1996;68(2-3):435-6. [PubMed]
- Craven R. Ketamine. Anaesthesia. 2007;62 Suppl 1:48-53. [Crossref] [PubMed]
- Choi EJ, Kim CH, Yoon JY, Kim EJ. Ketamine-propofol (ketofol) in procedural sedation: a narrative review. J Dent Anesth Pain Med. 2023;23(3):123-33. [Crossref] [PubMed] [PMC]
- Coulter FL, Hannam JA, Anderson BJ. Ketofol simulations for dosing in pediatric anesthesia. Paediatr Anaesth. 2014;24(8):806-12. [Crossref] [PubMed]
- Biricik E, Karacaer F, Güleç E, Sürmelioğlu Ö, Ilgınel M, Özcengiz D. Comparison of TIVA with different combinations of ketamine-propofol mixtures in pediatric patients. J Anesth. 2018;32(1):104-11. [Crossref] [PubMed]
- Wang W, Cai W, Shao H, Ni H. Assessing pediatric anesthesia outcomes and prognostic factors: a comparative study of ketamine vs. ketamine + propofol. Am J Transl Res. 2023;15(10):6095-105. [PubMed] [PMC]
- Kogan A, Efrat R, Katz J, Vidne BA. Propofol-ketamine mixture for anesthesia in pediatric patients undergoing cardiac catheterization. J Cardiothorac Vasc Anesth. 2003;17(6):691-3. [Crossref] [PubMed]
- Koruk S, Mizrak A, Kaya Ugur B, Ilhan O, Baspinar O, Oner U. Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: a prospective randomized study. Clin Ther. 2010;32(4):701-9. [Crossref] [PubMed]
- Schaffer MS, Snyder AM, Morrison JE. An assessment of desflurane for use during cardiac electrophysiological study and radiofrequency ablation of supraventricular dysrhythmias in children. Paediatr Anaesth. 2000;10(2):155-9. [Crossref] [PubMed]
- Kurth CD, Hyman D. Worldwide journey in pediatric anesthesia quality and safety. Paediatr Anaesth. 2022;32(11):1181-4. [Crossref] [PubMed]
- Trentman TL, Fassett SL, Mueller JT, Altemose GT. Airway interventions in the cardiac electrophysiology laboratory: a retrospective review. J Cardiothorac Vasc Anesth. 2009;23(6):841-5. [Crossref] [PubMed]
- Weyand S, Adam V, Biehler P, Hägele P, Hanger S, Heinzmann D, et al. Focal Pulsed Field Ablation for Atrial Arrhythmias: Efficacy and Safety under Deep Sedation. J Clin Med. 2024;13(2):576. [Crossref] [PubMed] [PMC]
- Vladinov G, Fermin L, Longini R, Ramos Y, Maratea E Jr. Choosing the anesthetic and sedative drugs for supraventricular tachycardia ablations: A focused review. Pacing Clin Electrophysiol. 2018;41(11):1555-63. [Crossref] [PubMed]
- Wutzler A, Huemer M, Boldt LH, Parwani AS, Attanasio P, Tscholl V, et al. Effects of deep sedation on cardiac electrophysiology in patients undergoing radiofrequency ablation of supraventricular tachycardia: impact of propofol and ketamine. Europace. 2013;15(7):1019-24. [Crossref] [PubMed]
- Foo TY, Mohd Noor N, Yazid MB, Fauzi MH, Abdull Wahab SF, Ahmad MZ. Ketamine-propofol (Ketofol) for procedural sedation and analgesia in children: a systematic review and meta-analysis. BMC Emerg Med. 2020;20(1):81. [Crossref] [PubMed] [PMC]
.: Process List